These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14592919)

  • 1. Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study.
    Meriggioli MN; Rowin J; Richman JG; Leurgans S
    Ann N Y Acad Sci; 2003 Sep; 998():494-9. PubMed ID: 14592919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil in the therapy of severe myasthenia gravis.
    Schneider C; Gold R; Reiners K; Toyka KV
    Eur Neurol; 2001; 46(2):79-82. PubMed ID: 11528156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability.
    Meriggioli MN; Ciafaloni E; Al-Hayk KA; Rowin J; Tucker-Lipscomb B; Massey JM; Sanders DB
    Neurology; 2003 Nov; 61(10):1438-40. PubMed ID: 14638974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil treatment of myasthenia gravis.
    Cahoon WD; Kockler DR
    Ann Pharmacother; 2006 Feb; 40(2):295-8. PubMed ID: 16403848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil and myasthenia gravis.
    Ciafaloni E
    Lupus; 2005; 14 Suppl 1():s46-9. PubMed ID: 15803932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil.
    Hauser RA; Malek AR; Rosen R
    Neurology; 1998 Sep; 51(3):912-3. PubMed ID: 9748061
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil for myasthenia gravis: an open-label pilot study.
    Ciafaloni E; Massey JM; Tucker-Lipscomb B; Sanders DB
    Neurology; 2001 Jan; 56(1):97-9. PubMed ID: 11148243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.
    Sanders DB; Hart IK; Mantegazza R; Shukla SS; Siddiqi ZA; De Baets MH; Melms A; Nicolle MW; Solomons N; Richman DP
    Neurology; 2008 Aug; 71(6):400-6. PubMed ID: 18434638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis.
    Muscle Study Group
    Neurology; 2008 Aug; 71(6):394-9. PubMed ID: 18434639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The muddle of mycophenolate mofetil in myasthenia.
    Benatar M; Rowland LP
    Neurology; 2008 Aug; 71(6):390-1. PubMed ID: 18678821
    [No Abstract]   [Full Text] [Related]  

  • 11. Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.
    Burns TM; Sanders DB; Kaminski HJ; Wolfe GI; Narayanaswami P; Venitz J
    Muscle Nerve; 2015 May; 51(5):635-7. PubMed ID: 25704880
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil: a new immunosuppressive approach. Successful treatment in a case of myasthenia gravis associated with incomplete lupus erythematosus syndrome and hepatitis C virus infection.
    Caponnetto C; Rossi E; Primavera A
    Eur Neurol; 2001; 46(1):53-4. PubMed ID: 11455187
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity.
    Lim AK; Donnan G; Chambers B; Ierino FL
    Intern Med J; 2007 Jan; 37(1):55-9. PubMed ID: 17199845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
    Hain B; Jordan K; Deschauer M; Zierz S
    Muscle Nerve; 2006 Apr; 33(4):575-80. PubMed ID: 16323216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil in myasthenia gravis: the unanswered question.
    Phan C; Sanders DB; Siddiqi ZA
    Expert Opin Pharmacother; 2008 Oct; 9(14):2545-51. PubMed ID: 18778192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressive disorder associated with mycophenolate mofetil.
    Draper HM
    Pharmacotherapy; 2008 Jan; 28(1):136-9. PubMed ID: 18154484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single fiber EMG as an outcome measure in myasthenia gravis: results from a double-blind, placebo-controlled trial.
    Meriggioli MN; Rowin J
    J Clin Neurophysiol; 2003; 20(5):382-5. PubMed ID: 14702000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
    Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM
    J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of myasthenia gravis with mycophenolate mofetil: a case report.
    Meriggioli MN; Rowin J
    Muscle Nerve; 2000 Aug; 23(8):1287-9. PubMed ID: 10918271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases.
    Schneider-Gold C; Hartung HP; Gold R
    Muscle Nerve; 2006 Sep; 34(3):284-91. PubMed ID: 16583368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.